Preclinical Evaluation of a Companion Diagnostic Radiopharmaceutical, [(18)F]PSMA-1007, in a Subcutaneous Prostate Cancer Xenograft Mouse Model

[Image: see text] Several radiolabeled prostate-specific membrane antigen (PSMA)-targeted agents have been developed for detecting prostate cancer, using positron emission tomography imaging and targeted radionuclide therapy. Among them, [(18)F]PSMA-1007 has several advantages, including a comparati...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Su Bin, Song, In Ho, Kim, Seon Yoo, Ko, Hae Young, Kil, Hee Seup, Chi, Dae Yoon, Giesel, Frederik L., Kopka, Klaus, Hoepping, Alexander, Chun, Joong-Hyun, Park, Hyun Soo, Yun, Mijin, Kim, Sang Eun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906735/
https://www.ncbi.nlm.nih.gov/pubmed/36583623
http://dx.doi.org/10.1021/acs.molpharmaceut.2c00788

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906735/
https://www.ncbi.nlm.nih.gov/pubmed/36583623
http://dx.doi.org/10.1021/acs.molpharmaceut.2c00788

Ejemplares similares